Clinical Trial Update: Selective Lipopolysaccharide Hemosorption in Maternal Sepsis [NA]

View source ↗

Summary

A clinical trial evaluating selective lipopolysaccharide hemosorption for maternal sepsis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Maternal Sepsis

Drugs mentioned

• Selective Lipopolysaccharide Hemosorption

Snippet

Sponsor: Efferon JSC | Conditions: Maternal sepsIs | NA | Status: COMPLETED